1. Home
  2. NEUE vs ITRM Comparison

NEUE vs ITRM Comparison

Compare NEUE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • ITRM
  • Stock Information
  • Founded
  • NEUE 2015
  • ITRM 2015
  • Country
  • NEUE United States
  • ITRM Ireland
  • Employees
  • NEUE N/A
  • ITRM N/A
  • Industry
  • NEUE
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEUE
  • ITRM Health Care
  • Exchange
  • NEUE NYSE
  • ITRM Nasdaq
  • Market Cap
  • NEUE 60.7M
  • ITRM 49.5M
  • IPO Year
  • NEUE 2021
  • ITRM 2018
  • Fundamental
  • Price
  • NEUE $7.35
  • ITRM $1.49
  • Analyst Decision
  • NEUE Hold
  • ITRM Strong Buy
  • Analyst Count
  • NEUE 1
  • ITRM 1
  • Target Price
  • NEUE $7.00
  • ITRM $5.00
  • AVG Volume (30 Days)
  • NEUE 19.3K
  • ITRM 635.0K
  • Earning Date
  • NEUE 03-06-2025
  • ITRM 02-07-2025
  • Dividend Yield
  • NEUE N/A
  • ITRM N/A
  • EPS Growth
  • NEUE N/A
  • ITRM N/A
  • EPS
  • NEUE N/A
  • ITRM N/A
  • Revenue
  • NEUE $996,890,000.00
  • ITRM N/A
  • Revenue This Year
  • NEUE N/A
  • ITRM N/A
  • Revenue Next Year
  • NEUE $9.44
  • ITRM $160.88
  • P/E Ratio
  • NEUE $2.16
  • ITRM N/A
  • Revenue Growth
  • NEUE N/A
  • ITRM N/A
  • 52 Week Low
  • NEUE $3.79
  • ITRM $0.81
  • 52 Week High
  • NEUE $11.35
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 61.05
  • ITRM 46.16
  • Support Level
  • NEUE $7.30
  • ITRM $1.42
  • Resistance Level
  • NEUE $7.66
  • ITRM $1.58
  • Average True Range (ATR)
  • NEUE 0.07
  • ITRM 0.11
  • MACD
  • NEUE -0.05
  • ITRM 0.02
  • Stochastic Oscillator
  • NEUE 26.19
  • ITRM 61.76

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: